SE448301B - Tripeptider och farmaceutiska kompositioner innehallande desamma - Google Patents

Tripeptider och farmaceutiska kompositioner innehallande desamma

Info

Publication number
SE448301B
SE448301B SE8004791A SE8004791A SE448301B SE 448301 B SE448301 B SE 448301B SE 8004791 A SE8004791 A SE 8004791A SE 8004791 A SE8004791 A SE 8004791A SE 448301 B SE448301 B SE 448301B
Authority
SE
Sweden
Prior art keywords
group
mixture
acid
ethyl acetate
symbols
Prior art date
Application number
SE8004791A
Other languages
English (en)
Swedish (sv)
Other versions
SE8004791L (sv
Inventor
J Bouchaudon
D Farge
C James
Original Assignee
Rhone Poulenc Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Ind filed Critical Rhone Poulenc Ind
Publication of SE8004791L publication Critical patent/SE8004791L/
Publication of SE448301B publication Critical patent/SE448301B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8004791A 1979-06-29 1980-06-27 Tripeptider och farmaceutiska kompositioner innehallande desamma SE448301B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7916844A FR2460289A1 (fr) 1979-06-29 1979-06-29 Nouveaux tripeptides, leur preparation et les medicaments qui les contiennent

Publications (2)

Publication Number Publication Date
SE8004791L SE8004791L (sv) 1980-12-30
SE448301B true SE448301B (sv) 1987-02-09

Family

ID=9227278

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8004791A SE448301B (sv) 1979-06-29 1980-06-27 Tripeptider och farmaceutiska kompositioner innehallande desamma

Country Status (16)

Country Link
US (1) US4916119A (fr)
JP (1) JPS5645447A (fr)
AU (2) AU546524B1 (fr)
BE (1) BE884076A (fr)
CH (1) CH647789A5 (fr)
DE (1) DE3024369A1 (fr)
DK (1) DK154434C (fr)
FR (1) FR2460289A1 (fr)
GB (1) GB2053230B (fr)
IE (1) IE49950B1 (fr)
IT (1) IT1131847B (fr)
LU (1) LU82569A1 (fr)
NL (1) NL8003761A (fr)
NZ (1) NZ194178A (fr)
SE (1) SE448301B (fr)
ZA (1) ZA803886B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK156252C (da) * 1979-07-31 1989-12-18 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf
JPS5645449A (en) * 1979-07-31 1981-04-25 Fujisawa Pharmaceut Co Ltd Novel peptide, its pharmaceutically acceptable salt and preparation of the same
JPS57114556A (en) * 1980-10-27 1982-07-16 Fujisawa Pharmaceut Co Ltd Novel peptide compound and its preparation
FR2496654A1 (fr) * 1980-12-19 1982-06-25 Rhone Poulenc Sante Nouveaux tri-, tetra- et pentapeptides, leur preparation et les medicaments qui les contiennent
GR79114B (fr) * 1981-01-29 1984-10-02 Fujisawa Pharmaceutical Co
JPH068312B2 (ja) * 1981-01-29 1994-02-02 藤沢薬品工業株式会社 新規ペプチドの製造法
JPS5835121A (ja) * 1981-08-20 1983-03-01 ビラス・ヴィー・リクハイト 免疫刺激性補助剤からなる抗原及び免疫療法におけるその使用
FR2619108B1 (fr) * 1987-08-07 1989-12-01 Rhone Poulenc Sante Procede de preparation de l'acide n6-benzyloxycarbonyl diamino-2,6 pimelamique sous les formes l,l ou d,d ou racemique
US7078165B2 (en) * 2003-03-27 2006-07-18 Institut Pasteur Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2442889A1 (fr) * 1978-10-19 1980-06-27 Anvar Nouveaux composes hydrosolubles provenant d'extraits de streptomyces stimulosus, leur obtention, leur application a titre d'adjuvants immunologiques et compositions les contenant
EP0011283B1 (fr) * 1978-11-14 1982-07-28 Fujisawa Pharmaceutical Co., Ltd. Lactyl-tétrapeptide, procédé pour sa préparation et compositions pharmaceutiques le contenant
US4311640A (en) * 1978-11-14 1982-01-19 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
DE2965017D1 (en) * 1978-12-22 1983-04-14 Anvar New compounds associating peptidyl or aminoacyl residues to lipophilic groups and pharmaceutical compositions containing said new compounds
JPS5645449A (en) * 1979-07-31 1981-04-25 Fujisawa Pharmaceut Co Ltd Novel peptide, its pharmaceutically acceptable salt and preparation of the same

Also Published As

Publication number Publication date
FR2460289A1 (fr) 1981-01-23
IT8023074A0 (it) 1980-06-26
DK154434B (da) 1988-11-14
US4916119A (en) 1990-04-10
IT1131847B (it) 1986-06-25
SE8004791L (sv) 1980-12-30
DE3024369A1 (de) 1981-01-15
JPH0159275B2 (fr) 1989-12-15
NL8003761A (nl) 1980-12-31
AU5969880A (en) 1981-01-08
CH647789A5 (fr) 1985-02-15
DK154434C (da) 1989-04-10
IE49950B1 (en) 1986-01-22
JPS5645447A (en) 1981-04-25
FR2460289B1 (fr) 1983-09-30
GB2053230B (en) 1983-03-16
BE884076A (fr) 1980-12-29
DK277180A (da) 1980-12-30
GB2053230A (en) 1981-02-04
NZ194178A (en) 1983-11-18
LU82569A1 (fr) 1981-02-02
IE801340L (en) 1980-12-29
ZA803886B (en) 1981-06-24
AU546524B1 (en) 1985-09-05

Similar Documents

Publication Publication Date Title
US11952434B2 (en) Immunomodulators
US4742048A (en) Tetrapeptides and pentapeptides, their preparation and compositions containing them
SE448301B (sv) Tripeptider och farmaceutiska kompositioner innehallande desamma
DK154436B (da) Analogifremgangsmaade til fremstilling af tri-, tetra- og pentapeptider eller salte deraf
JPH0378374B2 (fr)
JP2001526661A (ja) 20(s)−カンプトテシンの複合糖質
US4362716A (en) Dipeptides, their preparation and compositions containing them
JPH06509324A (ja) 新規ペプチド、その製造及び使用
NZ223509A (en) Tuftsin analogues containing a bicyclic nitrogen-containing residue and pharmaceutical compositions
CA2003984A1 (fr) Derive d'acide sialique avec des groupes ester actifs
DE4007605B4 (de) SDK-Peptide, Verfahren zu ihrer Herstellung und diese enthaltende therapeutischen Zusammensetzungen
JP3859270B2 (ja) アポトーシス誘導剤
Rüde et al. Specificity of H‐2‐linked Ir gene control in mice: recognition of defined sequence analogs of (T, G)‐A–L
EP0489220A1 (fr) Dérivés N,N-bis(succinyl-peptidiques) cytotoxiques d'1,4-bis(aminoalkyl)-5,8-dihydroxyanthraquinones et leurs conjuqués d'anticorps
TW202432559A (zh) 一類連接子藥物及其抗體-藥物偶聯物的製備方法和應用
CA3188364A1 (fr) Procedes de synthese de conjugues proteine-medicament
JPS59148748A (ja) ノナペプチド
BR112017009600B1 (pt) Peptídeos macrocíclicos úteis como imunomoduladores

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8004791-3

Effective date: 19930109

Format of ref document f/p: F